Showing 10,021 - 10,040 results of 60,155 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((teer decrease) OR (a decrease)) ))', query time: 0.92s Refine Results
  1. 10021
  2. 10022
  3. 10023
  4. 10024

    Study variables. by Amit Timilsina (15203538)

    Published 2025
    “…</p><p>Results</p><p>From 2011 to 2016, the prevalence of fever increased from 18% to 20%, while the prevalence of diarrhoea decreased from 14% to 7%, and ARI prevalence decreased from 5% to 3%. …”
  5. 10025

    Descriptive statistics. by Amit Timilsina (15203538)

    Published 2025
    “…</p><p>Results</p><p>From 2011 to 2016, the prevalence of fever increased from 18% to 20%, while the prevalence of diarrhoea decreased from 14% to 7%, and ARI prevalence decreased from 5% to 3%. …”
  6. 10026
  7. 10027
  8. 10028
  9. 10029
  10. 10030

    Percentage positive tests, tests turnaround times (24h-48h) and cumulative cases are reported from March 17, 2020 to November 28, 2020 in Toronto. by Elena Aruffo (11981366)

    Published 2022
    “…<p>The percentage positive tests decrease from May 31 to August 24, when it starts increasing, showing, however a magnitude smaller than the first wave in March. …”
  11. 10031

    Pyridoxine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  12. 10032

    Thiamine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  13. 10033

    Riboflavine forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  14. 10034

    Biotin forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…In compounding practice, a medication can be done extemporaneously, leading to a risk of error. …”
  15. 10035
  16. 10036

    Delay in head and neck cancer care during the COVID-19 pandemic and its impact on health outcomes by Claudiane MAHL (10412526)

    Published 2021
    “…Oncology services have been reorganized to decrease the risk of nosocomial acquisition of SARS-CoV-2, but changes in treatment pathways and follow-up cancer care can result in patients receiving suboptimal or delayed care. …”
  17. 10037

    Characteristics of dexmedetomidine use. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
  18. 10038

    Baseline characteristics. by Shi-Yuan Yu (17054536)

    Published 2023
    “…Forty-five percent of patients had ≥50% days of rousable sedation. Hypotension occurred in 85% of patients. …”
  19. 10039

    Data_Sheet_1_Impaired Retrograde Transport Due to Lack of TBC1D5 Contributes to the Trafficking Defect of Lysosomal Cathepsins in Ischemic/Hypoxic Cardiomyocytes.docx by Lin Cui (163750)

    Published 2021
    “…We also established that TBC1D5 was an important regulator of the distribution of lysosomal cathepsins. …”
  20. 10040

    Flow diagram of participant inclusion. by Makoto Shimoyama (17290996)

    Published 2023
    “…We used the Mann–Whitney U test for our analysis. …”